Filatenkov Alexander, Richardson Timothy E, Daoud Elena, Johnson-Welch Sarah F, Ramirez Denise M, Torrealba Jose, Greenberg Benjamin, Monson Nancy L, Rajaram Veena
Departments of aPathology bNeurology and Neurotherapeutics cPediatrics dImmunology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Neuroreport. 2017 Sep 27;28(14):890-895. doi: 10.1097/WNR.0000000000000851.
Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is an autoimmune disease mediated by IgG1 or IgG3 antibodies to the GluN1 subunit of the NMDAR, resulting in downregulation of NMDARs. Early diagnosis, prompt reduction of anti-NMDAR antibodies, and removal of associated ovarian tumors when identified are important drivers of prognosis. Immunohistochemical studies were carried out to evaluate B cell, plasma cell, and T-cell infiltrates in the brain of a 3-year-old patient with anti-NMDAR encephalitis who failed to show improvement after plasma exchange and Rituximab treatment. Complement activation was evaluated by C4d staining. Plasma cells and B-cells were rarely detected in the brain. In contrast, persistent intraparenchymal infiltrates and perivascular CD3+ T cells and evidence of complement activation were detected. Activated microglia and microglial nodules were also detected in the frontal lobes and the basal ganglia. The role of T cells and complement activation should be investigated in patients who do not respond to plasma exchange and Rituximab treatment.
抗 N-甲基-D-天冬氨酸受体(NMDAR)脑炎是一种自身免疫性疾病,由针对 NMDAR 的 GluN1 亚基的 IgG1 或 IgG3 抗体介导,导致 NMDAR 下调。早期诊断、迅速降低抗 NMDAR 抗体以及在发现相关卵巢肿瘤时将其切除是预后的重要决定因素。对一名 3 岁抗 NMDAR 脑炎患者进行了免疫组织化学研究,该患者在进行血浆置换和利妥昔单抗治疗后未显示出改善。通过 C4d 染色评估补体激活情况。在脑中很少检测到浆细胞和 B 细胞。相反,检测到脑实质内持续浸润以及血管周围 CD3+T 细胞和补体激活的证据。在额叶和基底神经节中也检测到活化的小胶质细胞和小胶质结节。对于对血浆置换和利妥昔单抗治疗无反应的患者,应研究 T 细胞和补体激活的作用。